have

(redirected from hae)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
See: accommodate, hold, keep, occupy, own, possess, remain, retain, shelter

TO HAVE. These words are used in deeds for the conveyance of land, in that clause which usually declared for what estate the land is granted. The same as Habendum. (q.v.) Vide Habendum; Tenendum.

References in periodicals archive ?
When administered at the onset of HAE attack symptoms at the recommended dose, RUCONEST works to return a patient's C1-INH levels to normal range and quickly begins to relieve the symptoms of an HAE attack with a low recurrence of symptoms.
While a very small number of people use HAE drugs, the increased use and costs call for high touch case management as an essential HAE management tool.
FIRAZYR is currently approved in 38 countries worldwide, including the countries of the European Union and the United States for the treatment of acute attacks of HAE in adults.
Overwhelming evidence suggests that the symptoms of HAE are mainly the result of a deficiency in the regulation ofthelatter pathway.
Because HAE often involves constant low-grade spontaneous activation of complement, C4 can also be low when patients are asymptomatic.
treatment of HAE, a rare hereditary condition characterized by episodes of acute swelling and inflammation that can peripherally affect the extremities (hands, feet, face), the abdominal tract, the genitalia, and in life- threatening cases, the larynx.
Safety and Efficacy of Recombinant Human C1 inhibitor for the Treatment of HAE Attacks in Pediatric Patients- Oral Presentation by Dr.
We re excited to offer the only recombinant C1 esterase inhibitor therapy for HAE in the United States, said Carolyn J.
May 14, 2014 /PRNewswire/ -- As a Diamond Sponsor of HAE Day on May 16, 2014, CSL Behring is proud to continue its partnership with HAEi, the International Patient Organization for C1 Inhibitor Deficiencies, and patient organizations throughout the world.
The study showed that patients receiving treatment with FIRAZYR experienced a significantly faster time to onset of symptom relief from individual and combined cutaneous and abdominal HAE symptoms, compared to those receiving placebo.
HAE Monitor Helps Patients and Physicians More Effectively Track HAE Symptoms and Improve Treatment Decisions